Cargando…
The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers
The COVID-19 pandemic resulted in temporary holds placed on new trial startups, patient recruitment and follow up visits for trials which contributed to major disruptions in cancer center trial unit operations. To assess the impact, the Canadian Cancer Clinical Trials Network (3CTN) members particip...
Autores principales: | Sundquist, Stephen, Kato, Diana, Xu, Rebecca Y., Schoales, James, Kulendran, Saranya, Dancey, Janet E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026465/ https://www.ncbi.nlm.nih.gov/pubmed/35448171 http://dx.doi.org/10.3390/curroncol29040197 |
Ejemplares similares
-
Advancing Academic Cancer Clinical Trials Recruitment in Canada
por: Xu, Rebecca Y., et al.
Publicado: (2021) -
CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
por: Sundquist, Stephen, et al.
Publicado: (2021) -
Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center
por: Morjaria, Sejal, et al.
Publicado: (2016) -
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
por: Hamm, Caroline, et al.
Publicado: (2022) -
Assessing Electronic Nicotine Delivery Systems Use at NCI-Designated Cancer Centers in the Cancer Moonshot–funded Cancer Center Cessation Initiative
por: D'Angelo, Heather, et al.
Publicado: (2021)